Barclays’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-49,170
Closed -$1.95M 4393
2024
Q1
$1.95M Sell
49,170
-31,127
-39% -$1.23M ﹤0.01% 1954
2023
Q4
$1.53M Buy
80,297
+71,171
+780% +$1.36M ﹤0.01% 2329
2023
Q3
$104K Buy
9,126
+2,801
+44% +$31.9K ﹤0.01% 3318
2023
Q2
$65K Sell
6,325
-5,754
-48% -$59.1K ﹤0.01% 3566
2023
Q1
$93K Buy
12,079
+5,999
+99% +$46.2K ﹤0.01% 3574
2022
Q4
$45K Buy
6,080
+5,418
+818% +$40.1K ﹤0.01% 3813
2022
Q3
$5K Sell
662
-121
-15% -$914 ﹤0.01% 4388
2022
Q2
$7K Sell
783
-1,103
-58% -$9.86K ﹤0.01% 4421
2022
Q1
$17K Sell
1,886
-12,212
-87% -$110K ﹤0.01% 4376
2021
Q4
$196K Buy
14,098
+9,351
+197% +$130K ﹤0.01% 2839
2021
Q3
$51K Buy
4,747
+3,278
+223% +$35.2K ﹤0.01% 3385
2021
Q2
$13K Sell
1,469
-12,636
-90% -$112K ﹤0.01% 3804
2021
Q1
$150K Buy
+14,105
New +$150K ﹤0.01% 3234
2020
Q4
Sell
-2,793
Closed -$25K 3744
2020
Q3
$25K Buy
+2,793
New +$25K ﹤0.01% 3466
2019
Q4
Sell
-2
Closed 4309
2019
Q3
$0 Buy
+2
New ﹤0.01% 4487
2018
Q2
Sell
-134
Closed -$1K 4439
2018
Q1
$1K Buy
+134
New +$1K ﹤0.01% 4150
2017
Q3
Sell
-675
Closed -$6K 4170
2017
Q2
$6K Buy
+675
New +$6K ﹤0.01% 3523
2017
Q1
Sell
-1,000
Closed -$9K 4185
2016
Q4
$9K Hold
1,000
﹤0.01% 3302
2016
Q3
$33K Sell
1,000
-24
-2% -$792 ﹤0.01% 2877
2016
Q2
$18K Buy
1,024
+24
+2% +$422 ﹤0.01% 2849
2016
Q1
$16K Hold
1,000
﹤0.01% 2835
2015
Q4
$28K Hold
1,000
﹤0.01% 2637
2015
Q3
$48K Buy
+1,000
New +$48K ﹤0.01% 2600